Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors

Article ID	Journal	Published Year	Pages	File Type
8457625	Nuclear Medicine and Biology	2018	28 Pages	PDF

Keywords

SSTR2 FDA Trifluoroborate DOTA somatostatin receptor type 2 AAA FDG FWHM EWOD TLC RLT RCY IEX 2-fluoro-2-deoxy-D-glucose RCP 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid Electrowetting-on-dielectric Isotopic exchange Clinical translation Neuroendocrine tumor neuroendocrine tumors Positron emission tomography NET radiochemical purity Food and Drug Administration Full-width Half Maximum Radiochemical yield NOTA PET high-performance liquid chromatography HPLC thin-layer chromatography

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research

Preview

Microscale radiosynthesis, preclinical imaging and dosimetry study of [18F]AMBF3-TATE: A potential PET tracer for clinical imaging of somatostatin receptors

Authors

Ksenia Lisova, Maxim Sergeev, Susan Evans-Axelsson, Andreea D. Stuparu, Seval Beykan, Jeffrey Collins, Jason Jones, Michael Lassmann, Ken Herrmann, David Perrin, Jason T. Lee, Roger Slavik, R. Michael van Dam,